Skip to main content
Clinical Trials/CTRI/2019/09/021354
CTRI/2019/09/021354Not yet recruitingPhase 1/2

Pharmaceutical,Analytical study and Exploratory Clinical Evaluation of Abha Guggulu prepared using Abha phala in Janusandhigatavata

DrMrinmayee Hedaoo1 site in 1 country12 target enrollmentStarted: October 30, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 1/2
Status
Not yet recruiting
Sponsor
Enrollment
12
Locations
1
Primary Endpoint
reduction in disease severity as seen in WOMAC scale

Study Overview

Brief Summary

This will be an exploratory clinical trial to check the efficacy of Abha Guggulu manufactured using Abha phala, in patients suffering from Knee joint OA.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Open Label

Eligibility Criteria

Ages
40.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Patients having signs and symptoms of sandhigatav vata affecting janu.
  • •2.All economic strata and prakruti.

Exclusion Criteria

  • •1.Patients with Rheumatoid Arthritis 2.Uncontrolled Hypertension 3.Diseases like paralysis,parkinsons disease,severe anaemia,cancer.
  • •4.secondary osteoarthritis due to tuberculosis,AIDS.

Outcomes

Primary Outcomes

reduction in disease severity as seen in WOMAC scale

Time Frame: 30 days

Secondary Outcomes

  • reduction in disease severity as seen in WOMAC scale(30 days)

Investigators

Sponsor
DrMrinmayee Hedaoo
Sponsor Class
Other [other(self)]

Study Sites (1)

Loading locations...

Similar Trials